FELBAMATE

FELBAMATE was reported 1779 times

FELBAMATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUCOPOLYSACCHARIDOSIS III 1 0.3333
1 BENZODIAZEPINE DRUG LEVEL DECREASED 3 0.2000
2 CEREBELLAR COGNITIVE AFFECTIVE SYNDROME 1 0.0714
3 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 2 0.0645
4 MEDICAL DEVICE ADJUSTMENT 1 0.0625
5 COOMBS TEST NEGATIVE 1 0.0625
6 CEREBRAL LOBOTOMY 1 0.0476
7 INFECTED INSECT BITE 1 0.0400
8 ATONIC SEIZURES 34 0.0396
9 INVOLUNTARY VOCALISATION 1 0.0345
10 CORPUS CALLOSOTOMY 1 0.0312
11 HYPOCITRATURIA 2 0.0308
12 VAGAL NERVE STIMULATOR IMPLANTATION 9 0.0294
13 LENNOX-GASTAUT SYNDROME 6 0.0264
14 LARYNGEAL STENOSIS 15 0.0260
15 NASOPHARYNGEAL REFLUX 1 0.0244
16 LISSENCEPHALY 1 0.0217
17 SEIZURE CLUSTER 18 0.0217
18 BLOOD KETONE BODY DECREASED 1 0.0213
19 MITRAL VALVE THICKENING 6 0.0201
20 COAGULATION FACTOR XIII LEVEL DECREASED 1 0.0192
21 AORTIC VALVE THICKENING 3 0.0186
22 MYRINGOTOMY 1 0.0185
23 BRAIN LOBECTOMY 1 0.0169
24 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 13 0.0167
25 PERSEVERATION 3 0.0161
26 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 8 0.0150
27 MEDICAL DEVICE BATTERY REPLACEMENT 2 0.0148
28 DRUG WITHDRAWAL CONVULSIONS 26 0.0146
29 HIGH-PITCHED CRYING 1 0.0141
30 MULTIPLE-DRUG RESISTANCE 42 0.0135
31 ANGIOFIBROMA 1 0.0135
32 LUNG INJURY 4 0.0132
33 INTESTINAL TRANSIT TIME DECREASED 1 0.0130
34 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 4 0.0129
35 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 14 0.0127
36 BACTERIAL TRACHEITIS 1 0.0123
37 EUTHYROID SICK SYNDROME 1 0.0118
38 PH URINE INCREASED 2 0.0116
39 SYSTOLIC DYSFUNCTION 12 0.0114
40 FRONTAL LOBE EPILEPSY 1 0.0103
41 VENTRICULAR FAILURE 3 0.0096
42 CHANGE IN SEIZURE PRESENTATION 6 0.0093
43 INTESTINAL ATRESIA 1 0.0093
44 PARANASAL SINUS MUCOSAL HYPERTROPHY 1 0.0084
45 FOCAL DYSCOGNITIVE SEIZURES 9 0.0079
46 TRACHEITIS 6 0.0079
47 HYPERCHLORAEMIA 5 0.0078
48 TONIC CONVULSION 11 0.0078
49 OEDEMATOUS KIDNEY 2 0.0075
50 ANTICONVULSANT DRUG LEVEL INCREASED 12 0.0074
51 NEUROPROSTHESIS IMPLANTATION 1 0.0072
52 PINEAL GLAND CYST 1 0.0071
53 ALKALOSIS HYPOCHLORAEMIC 1 0.0071
54 GASTROINTESTINAL STOMA OUTPUT DECREASED 1 0.0071
55 MENINGITIS STAPHYLOCOCCAL 1 0.0070
56 INFANTILE SPASMS 5 0.0069
57 PNEUMATOSIS 3 0.0067
58 MYOCLONIC EPILEPSY 10 0.0066
59 CORONARY ARTERY DILATATION 1 0.0064
60 DEVICE DEPENDENCE 1 0.0064
61 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 2 0.0063
62 ADENOCARCINOMA OF THE CERVIX 1 0.0062
63 FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD 1 0.0061
64 CERVIX CANCER METASTATIC 1 0.0061
65 HEPATIC ADENOMA 3 0.0058
66 INTRACARDIAC MASS 1 0.0056
67 CALCULUS URINARY 8 0.0052
68 PETIT MAL EPILEPSY 26 0.0051
69 HYPOCHROMASIA 1 0.0050
70 SIMPLE PARTIAL SEIZURES 4 0.0050
71 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
72 RETICULOCYTE COUNT DECREASED 2 0.0046
73 MONOCYTE COUNT ABNORMAL 1 0.0045
74 PLATELET FUNCTION TEST ABNORMAL 1 0.0045
75 PLEURAL INFECTION 1 0.0043
76 PROPOFOL INFUSION SYNDROME 3 0.0043
77 VENTRICULAR DYSFUNCTION 11 0.0042
78 NEUROGENIC BOWEL 1 0.0042
79 GENERALISED TONIC-CLONIC SEIZURE 68 0.0041
80 MICROCYTOSIS 1 0.0040
81 ADENOTONSILLECTOMY 1 0.0040
82 LEFT VENTRICULAR ENLARGEMENT 1 0.0039
83 OSCILLOPSIA 1 0.0039
84 GALLBLADDER OBSTRUCTION 1 0.0038
85 VENTRICULAR HYPOKINESIA 12 0.0037
86 NASAL NEOPLASM 1 0.0037
87 DEJA VU 1 0.0036
88 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
89 RESPIRATORY ACIDOSIS 14 0.0036
90 MOANING 4 0.0035
91 BEHAVIOUR DISORDER 19 0.0035
92 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 18 0.0035
93 ATRIOVENTRICULAR BLOCK FIRST DEGREE 15 0.0035
94 SELF-DESTRUCTIVE BEHAVIOUR 3 0.0034
95 DEFIANT BEHAVIOUR 1 0.0032
96 MEDICAL DEVICE SITE INFECTION 2 0.0032
97 SEIZURE 364 0.0031
98 HAEMATOLOGY TEST ABNORMAL 1 0.0031
99 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 2 0.0031
100 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
101 LIPOPROTEIN (A) INCREASED 1 0.0031
102 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
103 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
104 POSTICTAL STATE 3 0.0029
105 MENTAL RETARDATION 1 0.0029
106 ECHOCARDIOGRAM ABNORMAL 4 0.0029
107 MULTIPLE SYSTEM ATROPHY 1 0.0028
108 EYE SYMPTOM 1 0.0028
109 STATUS EPILEPTICUS 31 0.0027
110 PULMONARY VALVE INCOMPETENCE 4 0.0027
111 FEEDING TUBE USER 1 0.0027
112 CLONIC CONVULSION 2 0.0027
113 DIET REFUSAL 2 0.0027
114 ENTEROBACTER SEPSIS 1 0.0027
115 AURA 5 0.0027
116 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
117 GASTROSTOMY 4 0.0026
118 ADENOIDECTOMY 1 0.0026
119 METAPNEUMOVIRUS INFECTION 2 0.0026
120 AMMONIA ABNORMAL 1 0.0025
121 STARING 6 0.0025
122 CRANIOTOMY 1 0.0024
123 MEDICAL INDUCTION OF COMA 1 0.0024
124 APPARENT LIFE THREATENING EVENT 1 0.0024
125 FRONTOTEMPORAL DEMENTIA 1 0.0023
126 ENTEROVIRUS INFECTION 2 0.0023
127 FOOD REFUSAL 2 0.0023
128 UPPER AIRWAY OBSTRUCTION 2 0.0023
129 ANAEMIA MEGALOBLASTIC 1 0.0022
130 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
131 FEEDING INTOLERANCE 1 0.0022
132 SELECTIVE EATING DISORDER 2 0.0022
133 BRAIN OPERATION 5 0.0022
134 CONVULSION 124 0.0022
135 EATING DISORDER SYMPTOM 1 0.0022
136 TRICUSPID VALVE INCOMPETENCE 17 0.0021
137 MEAN CELL VOLUME ABNORMAL 1 0.0021
138 BLAST CELLS PRESENT 1 0.0021
139 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
140 RHINOVIRUS INFECTION 8 0.0021
141 BLINDNESS CORTICAL 1 0.0020
142 DROOLING 14 0.0020
143 EAR INJURY 1 0.0020
144 INTELLECTUAL DISABILITY 3 0.0020
145 INFANTILE SPITTING UP 1 0.0019
146 PARTIAL SEIZURES 10 0.0019
147 MEDICAL DEVICE CHANGE 1 0.0019
148 LEFT ATRIAL ENLARGEMENT 1 0.0019
149 EXECUTIVE DYSFUNCTION 1 0.0018
150 OPTIC ATROPHY 3 0.0018
151 AORTIC DILATATION 2 0.0018
152 HYPERAMMONAEMIA 9 0.0018
153 CARDIOTOXICITY 16 0.0018
154 BENIGN NEOPLASM 2 0.0018
155 ANENCEPHALY 1 0.0018
156 HEAD BANGING 1 0.0018
157 DROP ATTACKS 1 0.0017
158 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
159 GRAND MAL CONVULSION 15 0.0016
160 EPILEPSY 49 0.0016
161 DRUG LEVEL CHANGED 1 0.0016
162 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
163 LIP INJURY 2 0.0015
164 VISUAL FIELD DEFECT 11 0.0015
165 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
166 CHOREOATHETOSIS 1 0.0015
167 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
168 DEVELOPMENTAL DELAY 13 0.0014
169 ANTICONVULSANT DRUG LEVEL DECREASED 2 0.0014
170 DEVICE ELECTRICAL FINDING 1 0.0014
171 EYE ROLLING 1 0.0014
172 MUTISM 2 0.0014
173 AORTIC VALVE SCLEROSIS 1 0.0014
174 HEMIANOPIA HOMONYMOUS 1 0.0014
175 VENTRICULAR EXTRASYSTOLES 14 0.0013
176 SINUS BRADYCARDIA 13 0.0013
177 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
178 MITRAL VALVE INCOMPETENCE 15 0.0013
179 NYSTAGMUS 7 0.0013
180 CLAVICLE FRACTURE 5 0.0013
181 BILIRUBIN CONJUGATED INCREASED 3 0.0013
182 GRIMACING 1 0.0013
183 DRUG LEVEL DECREASED 13 0.0013
184 GALLBLADDER POLYP 1 0.0013
185 IMPLANT SITE EXTRAVASATION 1 0.0013
186 INAPPROPRIATE AFFECT 2 0.0013
187 INCISION SITE HAEMORRHAGE 1 0.0012
188 PULMONARY ARTERIAL PRESSURE INCREASED 2 0.0012
189 PRODUCT PREPARATION ISSUE 8 0.0012
190 PERITONEAL DIALYSIS 1 0.0012
191 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
192 ADRENAL MASS 1 0.0012
193 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
194 URINARY TRACT INFECTION BACTERIAL 3 0.0012
195 TYMPANIC MEMBRANE PERFORATION 2 0.0012
196 AORTIC VALVE INCOMPETENCE 5 0.0012
197 CRANIOFACIAL FRACTURE 1 0.0012
198 CRANIOSYNOSTOSIS 1 0.0012
199 APLASTIC ANAEMIA 6 0.0011
200 CEREBELLAR ATROPHY 1 0.0011
201 FACIAL BONES FRACTURE 4 0.0011
202 OBSESSIVE THOUGHTS 2 0.0011
203 ARTERIOVENOUS MALFORMATION 1 0.0011
204 CERUMEN IMPACTION 1 0.0011
205 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
206 CONDUCTION DISORDER 2 0.0011
207 BONE CONTUSION 1 0.0011
208 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
209 RASH MORBILLIFORM 3 0.0011
210 CEREBRAL PALSY 1 0.0011
211 HYPERVIGILANCE 1 0.0010
212 HYPOCOAGULABLE STATE 1 0.0010
213 BONE MARROW DEPRESSION 1 0.0010
214 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
215 HEMIANOPIA 1 0.0010
216 CARDIAC ANEURYSM 1 0.0010
217 HYPOTONIA 10 0.0010
218 SEDATION 26 0.0010
219 LIBIDO INCREASED 2 0.0010
220 IMPLANT SITE SWELLING 1 0.0010
221 PRODUCT SUPPLY ISSUE 7 0.0010
222 AMMONIA INCREASED 5 0.0010
223 INTERVERTEBRAL DISC COMPRESSION 1 0.0010
224 DILATATION VENTRICULAR 2 0.0010
225 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
226 PHARYNGEAL ERYTHEMA 2 0.0009
227 CIRCULATORY COLLAPSE 16 0.0009
228 NEUROMYOPATHY 1 0.0009
229 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0009
230 MYOCLONUS 11 0.0009
231 BLADDER DILATATION 1 0.0009
232 NEPHROSCLEROSIS 1 0.0009
233 COMPLEX PARTIAL SEIZURES 1 0.0009
234 POTENTIATING DRUG INTERACTION 3 0.0009
235 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
236 KLEBSIELLA SEPSIS 1 0.0009
237 LICHENOID KERATOSIS 2 0.0009
238 CORTISOL DECREASED 1 0.0009
239 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
240 PELVIC ABSCESS 1 0.0009
241 MACROCYTOSIS 1 0.0009
242 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
243 LIP ULCERATION 1 0.0009
244 DYSPLASIA 1 0.0008
245 DIABETES INSIPIDUS 2 0.0008
246 CHRONIC RESPIRATORY FAILURE 1 0.0008
247 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
248 SLOW SPEECH 2 0.0008
249 ENCEPHALITIS VIRAL 1 0.0008
250 BREATH ODOUR 2 0.0008
251 HAEMATOCRIT ABNORMAL 1 0.0008
252 BLOOD UREA DECREASED 1 0.0008
253 SALIVARY HYPERSECRETION 8 0.0008
254 PROTEIN TOTAL DECREASED 3 0.0008
255 LIP DISCOLOURATION 1 0.0008
256 NECROTISING COLITIS 1 0.0008
257 BRONCHIAL SECRETION RETENTION 1 0.0008
258 SCREAMING 5 0.0008
259 LEFT ATRIAL DILATATION 1 0.0008
260 HEPATIC INFECTION 1 0.0008
261 LACTOSE INTOLERANCE 2 0.0008
262 OVARIAN CYST RUPTURED 1 0.0008
263 PNEUMONIA ASPIRATION 19 0.0008
264 BLOOD LACTIC ACID INCREASED 4 0.0008
265 ATAXIA 9 0.0008
266 LACERATION 7 0.0007
267 CLUMSINESS 2 0.0007
268 CALCULUS BLADDER 1 0.0007
269 HEAD TITUBATION 1 0.0007
270 DRUG LEVEL INCREASED 12 0.0007
271 SOCIAL PROBLEM 3 0.0007
272 LETHARGY 41 0.0007
273 CULTURE URINE POSITIVE 1 0.0007
274 FANCONI SYNDROME 1 0.0007
275 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
276 AUDITORY DISORDER 1 0.0007
277 HYPERSOMNIA 20 0.0007
278 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
279 EXCESSIVE EYE BLINKING 1 0.0007
280 BRAIN NEOPLASM MALIGNANT 3 0.0007
281 AGGRESSION 33 0.0007
282 NEPHROLITHIASIS 30 0.0007
283 COAGULATION TIME PROLONGED 1 0.0006
284 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
285 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
286 TIBIA FRACTURE 3 0.0006
287 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
288 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
289 PNEUMONIA VIRAL 2 0.0006
290 CYSTITIS INTERSTITIAL 1 0.0006
291 COLON CANCER METASTATIC 1 0.0006
292 DIPLOPIA 16 0.0006
293 LIGAMENT SPRAIN 6 0.0006
294 ABNORMAL BEHAVIOUR 24 0.0006
295 ANTIBODY TEST POSITIVE 1 0.0006
296 MITRAL VALVE PROLAPSE 1 0.0006
297 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
298 APHASIA 18 0.0006
299 DEAFNESS BILATERAL 1 0.0006
300 ENTERITIS INFECTIOUS 1 0.0006
301 GAZE PALSY 1 0.0006
302 HYPOPITUITARISM 1 0.0006
303 OTORRHOEA 1 0.0006
304 MASTECTOMY 1 0.0006
305 SOMNOLENCE 114 0.0006
306 JOINT INJURY 12 0.0006
307 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
308 LOBAR PNEUMONIA 1 0.0005
309 BONE DENSITY ABNORMAL 2 0.0005
310 FACE INJURY 2 0.0005
311 MECHANICAL VENTILATION 1 0.0005
312 COMMUNICATION DISORDER 2 0.0005
313 ANKLE FRACTURE 8 0.0005
314 PRESCRIBED OVERDOSE 10 0.0005
315 CONCOMITANT DISEASE PROGRESSION 1 0.0005
316 NASAL SEPTUM DEVIATION 1 0.0005
317 JOINT CREPITATION 1 0.0005
318 PRODUCT SUBSTITUTION ISSUE 29 0.0005
319 COORDINATION ABNORMAL 7 0.0005
320 FOAMING AT MOUTH 1 0.0005
321 TREATMENT FAILURE 41 0.0005
322 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
323 EXTRAVASATION 2 0.0005
324 IMPULSE-CONTROL DISORDER 1 0.0005
325 SPINAL COMPRESSION FRACTURE 4 0.0005
326 IMPAIRED SELF-CARE 1 0.0005
327 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 2 0.0005
328 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
329 BODY TEMPERATURE FLUCTUATION 1 0.0005
330 CONGESTIVE CARDIOMYOPATHY 2 0.0005
331 PHYSICAL ASSAULT 1 0.0005
332 LIVEDO RETICULARIS 1 0.0005
333 DERMATITIS ALLERGIC 6 0.0005
334 SELF-INJURIOUS IDEATION 2 0.0005
335 FOOT FRACTURE 9 0.0005
336 IRRITABILITY 28 0.0005
337 DRUG INTERACTION 73 0.0005
338 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
339 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
340 URINE OUTPUT DECREASED 4 0.0005
341 MIDDLE EAR EFFUSION 1 0.0005
342 PHYSICAL DISABILITY 2 0.0005
343 TACHYCARDIA 40 0.0004
344 FAECES PALE 1 0.0004
345 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
346 HYPOPHAGIA 11 0.0004
347 IMPLANT SITE INFECTION 1 0.0004
348 BACTERAEMIA 5 0.0004
349 TOXICITY TO VARIOUS AGENTS 71 0.0004
350 COAGULOPATHY 7 0.0004
351 EOSINOPHIL COUNT DECREASED 1 0.0004
352 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
353 ADRENAL INSUFFICIENCY 5 0.0004
354 HEAD INJURY 13 0.0004
355 NO THERAPEUTIC RESPONSE 5 0.0004
356 BRONCHITIS CHRONIC 1 0.0004
357 CEREBRAL DISORDER 3 0.0004
358 DENTAL OPERATION 1 0.0004
359 FEELING DRUNK 3 0.0004
360 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
361 GASTROINTESTINAL TUBE INSERTION 1 0.0004
362 PLATELET DISORDER 1 0.0004
363 KLEBSIELLA INFECTION 2 0.0004
364 HYPOTHERMIA 4 0.0004
365 HOSTILITY 1 0.0004
366 DRUG DISPENSING ERROR 6 0.0004
367 MEAN CELL VOLUME INCREASED 1 0.0004
368 BLOOD CHLORIDE DECREASED 1 0.0004
369 FURUNCLE 3 0.0004
370 HEREDITARY ANGIOEDEMA 4 0.0004
371 PSYCHOTIC DISORDER 11 0.0004
372 HYDROCEPHALUS 2 0.0004
373 TIC 2 0.0004
374 BLOOD PHOSPHORUS INCREASED 1 0.0004
375 CLONUS 1 0.0004
376 HYPOMENORRHOEA 1 0.0004
377 LOWER LIMB FRACTURE 7 0.0004
378 HAIR DISORDER 3 0.0004
379 ELECTRIC SHOCK SENSATION 1 0.0004
380 ENDOTRACHEAL INTUBATION 1 0.0004
381 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
382 NEUTROPHIL COUNT ABNORMAL 1 0.0004
383 NECK MASS 1 0.0004
384 DRUG RESISTANCE 9 0.0004
385 CARDIAC VALVE DISEASE 2 0.0003
386 ELECTROLYTE IMBALANCE 4 0.0003
387 SKIN WARM 2 0.0003
388 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
389 SPLENOMEGALY 4 0.0003
390 ENERGY INCREASED 2 0.0003
391 EAR INFECTION 9 0.0003
392 CREPITATIONS 1 0.0003
393 WRIST FRACTURE 4 0.0003
394 METABOLIC ENCEPHALOPATHY 1 0.0003
395 TYPE 1 DIABETES MELLITUS 2 0.0003
396 HYPERCAPNIA 1 0.0003
397 RETCHING 7 0.0003
398 AGITATION 24 0.0003
399 SMALL INTESTINAL OBSTRUCTION 4 0.0003
400 DIASTOLIC DYSFUNCTION 1 0.0003
401 PERSONALITY CHANGE 3 0.0003
402 SCOLIOSIS 2 0.0003
403 MIDDLE INSOMNIA 6 0.0003
404 BLOOD CREATININE DECREASED 1 0.0003
405 BRAIN FOG 5 0.0003
406 EXPOSURE TO TOXIC AGENT 1 0.0003
407 BALANCE DISORDER 27 0.0003
408 CUSHINGOID 1 0.0003
409 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
410 AMNESIA 20 0.0003
411 RESPIRATORY TRACT INFECTION 8 0.0003
412 HYPOVENTILATION 1 0.0003
413 BRADYPHRENIA 2 0.0003
414 SOMNAMBULISM 2 0.0003
415 INJECTION SITE INFECTION 1 0.0003
416 LISTLESS 1 0.0003
417 CONDITION AGGRAVATED 92 0.0003
418 CEREBRAL HAEMATOMA 1 0.0003
419 METASTASES TO SPINE 1 0.0003
420 IMPAIRED GASTRIC EMPTYING 4 0.0003
421 EYE MOVEMENT DISORDER 2 0.0003
422 RIB FRACTURE 6 0.0003
423 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
424 PERIPHERAL COLDNESS 4 0.0003
425 DIFFICULTY IN WALKING 1 0.0003
426 CERVICAL VERTEBRAL FRACTURE 1 0.0003
427 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
428 HYPOPNOEA 1 0.0003
429 ROAD TRAFFIC ACCIDENT 12 0.0003
430 CARPAL TUNNEL SYNDROME 4 0.0003
431 BRONCHIOLITIS 1 0.0003
432 BODY HEIGHT DECREASED 3 0.0003
433 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
434 APPARENT DEATH 1 0.0003
435 PHARYNGITIS STREPTOCOCCAL 3 0.0003
436 GASTROENTERITIS VIRAL 5 0.0003
437 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
438 SKIN LACERATION 3 0.0003
439 HYPOKINESIA 4 0.0003
440 FAECES SOFT 2 0.0003
441 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
442 UTERINE LEIOMYOMA 2 0.0003
443 UNRESPONSIVE TO STIMULI 7 0.0003
444 AMYLASE INCREASED 1 0.0003
445 URINARY INCONTINENCE 8 0.0003
446 AGRANULOCYTOSIS 5 0.0003
447 HYPERACUSIS 1 0.0003
448 HEPATIC FUNCTION ABNORMAL 10 0.0003
449 HYDRONEPHROSIS 2 0.0003
450 CARDIAC ARREST 22 0.0003
451 EYE INFECTION 3 0.0003
452 REBOUND EFFECT 3 0.0003
453 HAEMODYNAMIC INSTABILITY 2 0.0003
454 INSURANCE ISSUE 4 0.0003
455 GASTRIC INFECTION 1 0.0003
456 ACUTE RESPIRATORY FAILURE 5 0.0003
457 EAR PAIN 5 0.0003
458 MOOD ALTERED 7 0.0003
459 CARDIOPULMONARY FAILURE 1 0.0003
460 DRUG-INDUCED LIVER INJURY 8 0.0003
461 RESPIRATORY DISTRESS 7 0.0003
462 PNEUMOTHORAX 4 0.0003
463 MENTAL STATUS CHANGES 7 0.0003
464 UPPER LIMB FRACTURE 5 0.0003
465 CEREBRAL ATROPHY 1 0.0003
466 ORGAN FAILURE 1 0.0002
467 ENURESIS 1 0.0002
468 FRUSTRATION TOLERANCE DECREASED 2 0.0002
469 HALLUCINATIONS, MIXED 1 0.0002
470 ANGER 8 0.0002
471 HEMIPARESIS 4 0.0002
472 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
473 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
474 PRODUCT CONTAINER ISSUE 2 0.0002
475 PSEUDOMONAS INFECTION 2 0.0002
476 BLOOD MAGNESIUM DECREASED 2 0.0002
477 RASH GENERALISED 6 0.0002
478 OCULAR ICTERUS 1 0.0002
479 BEDRIDDEN 3 0.0002
480 GINGIVAL SWELLING 1 0.0002
481 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
482 THERAPY NON-RESPONDER 10 0.0002
483 DYSKINESIA 9 0.0002
484 HOSPITALISATION 34 0.0002
485 LIP DRY 2 0.0002
486 DECREASED APPETITE 51 0.0002
487 METABOLIC ACIDOSIS 7 0.0002
488 EAR DISORDER 1 0.0002
489 LUMBAR VERTEBRAL FRACTURE 1 0.0002
490 BRAIN NEOPLASM 2 0.0002
491 MUSCLE TWITCHING 5 0.0002
492 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
493 DYSARTHRIA 8 0.0002
494 SEASONAL ALLERGY 3 0.0002
495 ENDOMETRIOSIS 1 0.0002
496 HYPOVOLAEMIC SHOCK 1 0.0002
497 AFFECT LABILITY 2 0.0002
498 APHAGIA 1 0.0002
499 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
500 DYSSTASIA 6 0.0002
501 VITAMIN D DEFICIENCY 2 0.0002
502 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
503 WEIGHT DECREASED 57 0.0002
504 ENCEPHALOPATHY 5 0.0002
505 ABDOMINAL TENDERNESS 1 0.0002
506 HEPATIC ENZYME ABNORMAL 1 0.0002
507 OVARIAN CYST 2 0.0002
508 DRUG INEFFECTIVE 263 0.0002
509 BRAIN INJURY 2 0.0002
510 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
511 CORONARY ARTERIAL STENT INSERTION 1 0.0002
512 FEEDING DISORDER 4 0.0002
513 MOTOR DYSFUNCTION 2 0.0002
514 EUPHORIC MOOD 2 0.0002
515 OSTEOPOROSIS 8 0.0002
516 FOETAL DEATH 1 0.0002
517 COGNITIVE DISORDER 9 0.0002
518 MALABSORPTION 1 0.0002
519 RESTLESSNESS 7 0.0002
520 WEIGHT FLUCTUATION 2 0.0002
521 CATATONIA 1 0.0002
522 PRODUCT USE COMPLAINT 3 0.0002
523 DYSURIA 7 0.0002
524 FOOD CRAVING 1 0.0002
525 MOUTH ULCERATION 4 0.0002
526 INCONTINENCE 2 0.0002
527 JOINT DISLOCATION 2 0.0002
528 BRADYCARDIA 10 0.0002
529 PHARYNGOLARYNGEAL PAIN 1 0.0002
530 LEARNING DISABILITY 1 0.0002
531 POOR QUALITY SLEEP 4 0.0002
532 BRUXISM 1 0.0002
533 DECREASED ACTIVITY 2 0.0002
534 BLOOD POTASSIUM INCREASED 3 0.0002
535 FALL 61 0.0002
536 OESOPHAGITIS 2 0.0002
537 ASPIRATION 2 0.0002
538 AUTISM SPECTRUM DISORDER 1 0.0002
539 PRODUCT USE IN UNAPPROVED INDICATION 45 0.0002
540 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
541 VIRAL INFECTION 6 0.0002
542 STEVENS-JOHNSON SYNDROME 4 0.0002
543 URINARY RETENTION 6 0.0002
544 GAIT INABILITY 6 0.0002
545 HEART RATE ABNORMAL 1 0.0002
546 ORAL PAIN 4 0.0002
547 SKIN INFECTION 2 0.0002
548 RESPIRATORY FAILURE 13 0.0002
549 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
550 BLOOD CALCIUM DECREASED 2 0.0002
551 DISORIENTATION 7 0.0002
552 PARANOIA 3 0.0002
553 MOUTH SWELLING 1 0.0002
554 SPEECH DISORDER 9 0.0002
555 PANCREATITIS 9 0.0002
556 PRODUCT DOSE OMISSION 11 0.0002
557 ACCIDENT 2 0.0002
558 ADVERSE DRUG REACTION 15 0.0002
559 WITHDRAWAL SYNDROME 7 0.0002
560 HEPATITIS CHOLESTATIC 1 0.0002
561 LACRIMATION INCREASED 5 0.0002
562 CRYING 6 0.0002
563 DERMATITIS ACNEIFORM 1 0.0002
564 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
565 PIGMENTATION DISORDER 1 0.0002
566 OLIGURIA 1 0.0002
567 ILEUS 2 0.0002
568 BACTERIAL INFECTION 3 0.0002
569 PNEUMONIA 52 0.0002
570 SECRETION DISCHARGE 2 0.0002
571 BLEPHAROSPASM 1 0.0002
572 URINARY TRACT INFECTION 27 0.0002
573 PHOTOPSIA 1 0.0002
574 DRUG DOSE OMISSION 26 0.0002
575 SLEEP APNOEA SYNDROME 3 0.0002
576 HAEMOGLOBIN ABNORMAL 1 0.0002
577 DYSTONIA 3 0.0002
578 INCOHERENT 1 0.0002
579 HEPATITIS ACUTE 1 0.0002
580 CHOKING 3 0.0002
581 SURGERY 9 0.0002
582 VOMITING 72 0.0002
583 OFF LABEL USE 134 0.0002
584 GAIT DISTURBANCE 29 0.0002
585 APPETITE DISORDER 1 0.0002
586 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
587 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
588 QUALITY OF LIFE DECREASED 2 0.0001
589 INTENTIONAL SELF-INJURY 3 0.0001
590 STOMATITIS 9 0.0001
591 SINUS CONGESTION 2 0.0001
592 BONE MARROW FAILURE 3 0.0001
593 DRUG TOXICITY 2 0.0001
594 ABNORMAL LOSS OF WEIGHT 1 0.0001
595 NEPHROTIC SYNDROME 1 0.0001
596 HYPOGLYCAEMIA 7 0.0001
597 APHONIA 2 0.0001
598 HAND FRACTURE 1 0.0001
599 METASTASIS 1 0.0001
600 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
601 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
602 DRUG EFFECT INCOMPLETE 5 0.0001
603 APATHY 2 0.0001
604 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
605 RASH MACULO-PAPULAR 3 0.0001
606 WEIGHT INCREASED 30 0.0001
607 RESPIRATORY DISORDER 4 0.0001
608 KETOACIDOSIS 1 0.0001
609 BLOOD POTASSIUM DECREASED 4 0.0001
610 PYREXIA 46 0.0001
611 HALLUCINATION 10 0.0001
612 TREMOR 22 0.0001
613 PAROSMIA 1 0.0001
614 ACIDOSIS 1 0.0001
615 BOWEL MOVEMENT IRREGULARITY 1 0.0001
616 LIPASE INCREASED 1 0.0001
617 DISSOCIATION 1 0.0001
618 OVERDOSE 28 0.0001
619 THYROID DISORDER 2 0.0001
620 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
621 CONCUSSION 1 0.0001
622 BLOOD CHOLESTEROL INCREASED 6 0.0001
623 APNOEA 1 0.0001
624 SLEEP DISORDER 9 0.0001
625 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
626 CYANOSIS 2 0.0001
627 DRUG SCREEN POSITIVE 1 0.0001
628 DYSPHAGIA 12 0.0001
629 RESPIRATORY TRACT CONGESTION 2 0.0001
630 ASPHYXIA 1 0.0001
631 HICCUPS 1 0.0001
632 HYPERAESTHESIA 1 0.0001
633 ESCHERICHIA INFECTION 1 0.0001
634 MANIA 2 0.0001
635 ABASIA 3 0.0001
636 BLOOD UREA INCREASED 2 0.0001
637 NASAL CONGESTION 7 0.0001
638 HAEMODIALYSIS 1 0.0001
639 CANDIDA INFECTION 2 0.0001
640 MEMORY IMPAIRMENT 16 0.0001
641 HAEMATOMA 3 0.0001
642 NAIL DISORDER 1 0.0001
643 EOSINOPHILIA 2 0.0001
644 HYPOXIA 4 0.0001
645 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
646 RENAL FAILURE 15 0.0001
647 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
648 DEHYDRATION 15 0.0001
649 FATIGUE 87 0.0001
650 GASTROINTESTINAL INFECTION 1 0.0001
651 JAUNDICE 3 0.0001
652 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
653 DISTURBANCE IN ATTENTION 6 0.0001
654 ANAL INCONTINENCE 1 0.0001
655 BLOOD BILIRUBIN INCREASED 3 0.0001
656 LIMB INJURY 3 0.0001
657 LUPUS-LIKE SYNDROME 1 0.0001
658 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
659 OPTIC NEURITIS 1 0.0001
660 INSOMNIA 29 0.0001
661 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
662 IRON DEFICIENCY ANAEMIA 1 0.0001
663 PANCYTOPENIA 6 0.0001
664 DEMENTIA 3 0.0001
665 THINKING ABNORMAL 2 0.0001
666 ERYTHEMA MULTIFORME 1 0.0001
667 APPENDICITIS 1 0.0001
668 BLOOD SODIUM DECREASED 2 0.0001
669 FRACTURE 2 0.0001
670 CONSTIPATION 23 0.0001
671 HAEMATOTOXICITY 1 0.0001
672 GASTRIC ULCER 2 0.0001
673 INCREASED APPETITE 2 0.0001
674 DRUG PRESCRIBING ERROR 2 0.0001
675 GLAUCOMA 2 0.0001
676 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
677 MENORRHAGIA 2 0.0001
678 HEPATOMEGALY 1 0.0001
679 HAEMATOCRIT DECREASED 2 0.0001
680 CONFUSIONAL STATE 16 0.0001
681 BLINDNESS 4 0.0001
682 BODY TEMPERATURE INCREASED 2 0.0001
683 DRUG ADMINISTRATION ERROR 3 0.0001
684 INITIAL INSOMNIA 1 0.0001
685 PRODUCT PREPARATION ERROR 2 0.0001
686 HELICOBACTER INFECTION 1 0.0001
687 PETECHIAE 1 0.0001
688 PRODUCT DOSE OMISSION ISSUE 28 0.0001
689 DIARRHOEA 61 0.0001
690 CYSTITIS 3 0.0001
691 MOOD SWINGS 3 0.0001
692 EATING DISORDER 2 0.0001
693 HIP FRACTURE 3 0.0001
694 RHINORRHOEA 6 0.0001
695 ACNE 7 0.0001
696 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
697 NASOPHARYNGITIS 17 0.0001
698 SEPTIC SHOCK 4 0.0001
699 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
700 TREATMENT NONCOMPLIANCE 5 0.0001
701 STAPHYLOCOCCAL INFECTION 3 0.0001
702 DENTAL CARIES 1 0.0001
703 LIP SWELLING 3 0.0001
704 FUNGAL INFECTION 3 0.0001
705 MEDICATION ERROR 5 0.0001
706 TRANSAMINASES INCREASED 2 0.0001
707 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
708 SEPSIS 10 0.0001
709 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
710 GASTROINTESTINAL DISORDER 8 0.0001
711 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
712 IMPAIRED DRIVING ABILITY 1 0.0001
713 MYOCARDIAL ISCHAEMIA 1 0.0001
714 ADVERSE EVENT 8 0.0001
715 PERICARDIAL EFFUSION 2 0.0001
716 DIZZINESS 43 0.0001
717 EYELID OEDEMA 1 0.0001
718 COUGH 24 0.0001
719 HEART RATE DECREASED 3 0.0001
720 ARRHYTHMIA 4 0.0001
721 DISEASE RECURRENCE 4 0.0001
722 PRODUCT PRESCRIBING ERROR 2 0.0001
723 CHOLECYSTITIS 1 0.0001
724 MACULAR DEGENERATION 1 0.0001
725 MUSCLE RIGIDITY 1 0.0001
726 BLOOD GLUCOSE DECREASED 4 0.0001
727 INCORRECT DOSE ADMINISTERED 19 0.0001
728 VERTIGO 5 0.0001
729 CYTOPENIA 1 0.0001
730 GENERALISED OEDEMA 1 0.0001
731 INFLUENZA 9 0.0001
732 EYE SWELLING 3 0.0001
733 PHARYNGITIS 1 0.0001
734 CYST 1 0.0001
735 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
736 THROMBOCYTOPENIA 9 0.0001
737 MUSCULOSKELETAL STIFFNESS 7 0.0001
738 ASTHENIA 30 0.0001
739 CELLULITIS 4 0.0001
740 BRAIN OEDEMA 1 0.0001
741 HEPATITIS 2 0.0001
742 SINUSITIS 8 0.0001
743 MYDRIASIS 1 0.0001
744 ABDOMINAL PAIN UPPER 16 0.0001
745 ANOREXIA 1 0.0001
746 INJECTION SITE INDURATION 1 0.0001
747 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
748 PLATELET COUNT INCREASED 1 0.0001
749 ABDOMINAL DISTENSION 8 0.0001
750 DYSMENORRHOEA 1 0.0001
751 ADVERSE REACTION 1 0.0001
752 HYPOTENSION 15 0.0001
753 JOINT RANGE OF MOTION DECREASED 1 0.0001
754 FEAR 2 0.0001
755 PRODUCT QUALITY ISSUE 10 0.0001
756 PALLOR 2 0.0001
757 RASH 32 0.0001
758 GINGIVAL BLEEDING 1 0.0001
759 SKIN LESION 2 0.0001
760 ORAL DISCOMFORT 1 0.0001
761 HUNGER 1 0.0001
762 OXYGEN SATURATION DECREASED 4 0.0001
763 BLOOD TEST ABNORMAL 1 0.0001
764 HYPONATRAEMIA 4 0.0001
765 BLINDNESS UNILATERAL 1 0.0001
766 TARDIVE DYSKINESIA 2 0.0001
767 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
768 DIALYSIS 1 0.0001
769 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
770 LOSS OF CONSCIOUSNESS 9 0.0001
771 INTENTIONAL DOSE OMISSION 2 0.0001
772 RED BLOOD CELL COUNT DECREASED 2 0.0001
773 MENTAL DISORDER 3 0.0001
774 DYSPHONIA 4 0.0001
775 PALPITATIONS 8 0.0001
776 LABORATORY TEST ABNORMAL 2 0.0001
777 CARDIOMYOPATHY 1 0.0001
778 BRONCHITIS 5 0.0001
779 HAEMORRHAGE INTRACRANIAL 1 0.0001
780 EPISTAXIS 5 0.0001
781 HYPOAESTHESIA ORAL 1 0.0001
782 THERAPEUTIC RESPONSE DECREASED 4 0.0001
783 BLOOD COUNT ABNORMAL 1 0.0001
784 OSTEOPENIA 1 0.0001
785 HIP ARTHROPLASTY 1 0.0001
786 SKIN DISCOLOURATION 3 0.0001
787 PHARYNGEAL OEDEMA 1 0.0001
788 EMOTIONAL DISORDER 2 0.0001
789 GYNAECOMASTIA 2 0.0001
790 DELUSION 1 0.0001
791 EJECTION FRACTION DECREASED 1 0.0001
792 HALLUCINATION, AUDITORY 1 0.0001
793 MIGRAINE 6 0.0001
794 PRODUCTIVE COUGH 3 0.0001
795 RASH ERYTHEMATOUS 3 0.0001
796 FEELING ABNORMAL 15 0.0001
797 MOVEMENT DISORDER 2 0.0001
798 DRUG INTOLERANCE 6 0.0001
799 HYPERTENSION 13 0.0001
800 BLOOD CREATININE INCREASED 4 0.0001
801 MULTIPLE FRACTURES 1 0.0001
802 EYE DISORDER 2 0.0001
803 PHOTOSENSITIVITY REACTION 1 0.0001
804 VISUAL ACUITY REDUCED 2 0.0001
805 ABDOMINAL PAIN 14 0.0001
806 NAUSEA 47 0.0001
807 HEPATIC ENZYME INCREASED 4 0.0001
808 METRORRHAGIA 1 0.0001
809 PRODUCT USE ISSUE 11 0.0001
810 GASTRIC DISORDER 2 0.0001
811 ILLNESS 6 0.0001
812 ORTHOSTATIC HYPOTENSION 1 0.0001
813 NERVOUSNESS 3 0.0001
814 ECZEMA 3 0.0001
815 LOCAL SWELLING 1 0.0001
816 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
817 AMENORRHOEA 1 0.0001
818 INJURY 4 0.0001
819 DEPRESSED MOOD 3 0.0001
820 HEAD DISCOMFORT 1 0.0001
821 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
822 CEREBRAL HAEMORRHAGE 2 0.0001
823 GOUT 1 0.0001
824 DRUG EFFECT DECREASED 3 0.0001
825 RASH PRURITIC 3 0.0001
826 LEUKOCYTOSIS 1 0.0001
827 BONE DISORDER 1 0.0001
828 UNDERDOSE 4 0.0001
829 ACCIDENTAL OVERDOSE 2 0.0001
830 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
831 CONJUNCTIVITIS 1 0.0001
832 HEPATIC STEATOSIS 1 0.0001
833 ABDOMINAL DISCOMFORT 9 0.0001
834 UNEVALUABLE EVENT 4 0.0001
835 DEPRESSION 12 0.0001
836 MUSCULOSKELETAL DISORDER 1 0.0001
837 FEELING JITTERY 1 0.0001
838 CONTUSION 5 0.0001
839 PERIPHERAL SWELLING 8 0.0001
840 ERUCTATION 1 0.0001
841 ORAL HERPES 1 0.0001
842 DISABILITY 1 0.0001
843 CATARACT 3 0.0001
844 MALAISE 22 0.0001
845 ABORTION SPONTANEOUS 2 0.0000
846 CARDIAC FAILURE CONGESTIVE 4 0.0000
847 EXTRA DOSE ADMINISTERED 2 0.0000
848 PLEURAL EFFUSION 3 0.0000
849 HYPERSENSITIVITY 9 0.0000
850 VISUAL IMPAIRMENT 6 0.0000
851 EXPOSURE DURING PREGNANCY 3 0.0000
852 INTENTIONAL DRUG MISUSE 1 0.0000
853 OSTEOARTHRITIS 2 0.0000
854 IMPAIRED WORK ABILITY 1 0.0000
855 LIVER FUNCTION TEST INCREASED 1 0.0000
856 HYPERHIDROSIS 6 0.0000
857 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
858 SWELLING FACE 3 0.0000
859 ALOPECIA 9 0.0000
860 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
861 DRUG WITHDRAWAL SYNDROME 4 0.0000
862 MELAENA 1 0.0000
863 ANGIOEDEMA 2 0.0000
864 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
865 HEADACHE 28 0.0000
866 PANCREATITIS ACUTE 1 0.0000
867 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
868 CHROMATURIA 1 0.0000
869 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
870 SUICIDAL IDEATION 4 0.0000
871 HYPOKALAEMIA 2 0.0000
872 CHILLS 5 0.0000
873 BLOOD PRESSURE FLUCTUATION 1 0.0000
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
875 INFECTION 6 0.0000
876 JOINT SWELLING 5 0.0000
877 LOCALISED INFECTION 1 0.0000
878 MENTAL IMPAIRMENT 1 0.0000
879 OEDEMA PERIPHERAL 5 0.0000
880 LIVER INJURY 1 0.0000
881 DYSPEPSIA 4 0.0000
882 DRY EYE 2 0.0000
883 COVID-19 7 0.0000
884 HAEMATEMESIS 1 0.0000
885 ANAPHYLACTIC SHOCK 1 0.0000
886 EXPOSURE VIA SKIN CONTACT 1 0.0000
887 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
888 CHEST PAIN 7 0.0000
889 MENSTRUATION IRREGULAR 1 0.0000
890 ABNORMAL DREAMS 1 0.0000
891 FEELING COLD 1 0.0000
892 ASTHMA 4 0.0000
893 DYSPNOEA 20 0.0000
894 MUSCULAR WEAKNESS 4 0.0000
895 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
896 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
897 PRODUCT STORAGE ERROR 3 0.0000
898 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
899 ASCITES 1 0.0000
900 DISEASE PROGRESSION 4 0.0000
901 HEPATIC FAILURE 1 0.0000
902 NO ADVERSE EVENT 6 0.0000
903 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
904 CORONARY ARTERY DISEASE 1 0.0000
905 ILL-DEFINED DISORDER 2 0.0000
906 DISCOMFORT 2 0.0000
907 LIMB DISCOMFORT 1 0.0000
908 FEMUR FRACTURE 1 0.0000
909 CARDIAC DISORDER 3 0.0000
910 NERVOUS SYSTEM DISORDER 1 0.0000
911 BONE DENSITY DECREASED 1 0.0000
912 ANXIETY 9 0.0000
913 INTENTIONAL OVERDOSE 2 0.0000
914 NIGHT SWEATS 1 0.0000
915 CHOLELITHIASIS 1 0.0000
916 HEART RATE INCREASED 3 0.0000
917 INFUSION RELATED REACTION 2 0.0000
918 BLOOD PRESSURE DECREASED 2 0.0000
919 EXPIRED PRODUCT ADMINISTERED 1 0.0000
920 SYNCOPE 3 0.0000
921 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
922 NEUTROPENIA 4 0.0000
923 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
924 VISION BLURRED 4 0.0000
925 NIGHTMARE 1 0.0000
926 DELIRIUM 1 0.0000
927 MYOCARDIAL INFARCTION 5 0.0000
928 HYPERKALAEMIA 1 0.0000
929 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
930 DEATH 22 0.0000
931 CARDIAC FAILURE 2 0.0000
932 THROMBOSIS 2 0.0000
933 NEUTROPHIL COUNT DECREASED 1 0.0000
934 URTICARIA 4 0.0000
935 RENAL IMPAIRMENT 2 0.0000
936 MYALGIA 4 0.0000
937 LIVER DISORDER 1 0.0000
938 OROPHARYNGEAL PAIN 2 0.0000
939 PAIN 13 0.0000
940 PULMONARY EMBOLISM 2 0.0000
941 NEUROPATHY PERIPHERAL 2 0.0000
942 ANAEMIA 4 0.0000
943 PAIN IN EXTREMITY 6 0.0000
944 HYPOAESTHESIA 3 0.0000
945 FLUSHING 2 0.0000
946 FLUID RETENTION 1 0.0000
947 CHEST DISCOMFORT 2 0.0000
948 HAEMOGLOBIN DECREASED 2 0.0000
949 ERYTHEMA 4 0.0000
950 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
951 INFLAMMATION 1 0.0000
952 ARTHRALGIA 8 0.0000
953 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
954 HAEMORRHAGE 2 0.0000
955 MUSCULOSKELETAL PAIN 1 0.0000
956 PLATELET COUNT DECREASED 2 0.0000
957 HAEMATOCHEZIA 1 0.0000
958 ANAPHYLACTIC REACTION 1 0.0000
959 ARTHROPATHY 1 0.0000
960 NECK PAIN 1 0.0000
961 BLISTER 1 0.0000
962 EYE PAIN 1 0.0000
963 FLATULENCE 1 0.0000
964 HERPES ZOSTER 1 0.0000
965 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
966 BONE PAIN 1 0.0000
967 MUSCLE SPASMS 3 0.0000
968 FEELING HOT 1 0.0000
969 DEVICE DIFFICULT TO USE 1 0.0000
970 FEBRILE NEUTROPENIA 1 0.0000
971 NEOPLASM MALIGNANT 1 0.0000
972 INJECTION SITE REACTION 1 0.0000
973 BURNING SENSATION 1 0.0000
974 MOBILITY DECREASED 1 0.0000
975 CHRONIC KIDNEY DISEASE 1 0.0000
976 ACUTE KIDNEY INJURY 2 0.0000
977 INJECTION SITE SWELLING 1 0.0000
978 PRURITUS 5 0.0000
979 ARTHRITIS 1 0.0000
980 PARAESTHESIA 2 0.0000
981 INJECTION SITE HAEMORRHAGE 1 0.0000
982 INFLUENZA LIKE ILLNESS 1 0.0000
983 COMPLETED SUICIDE 1 0.0000
984 CEREBROVASCULAR ACCIDENT 2 0.0000
985 INTENTIONAL PRODUCT MISUSE 1 0.0000
986 DEVICE ISSUE 1 0.0000
987 BLOOD GLUCOSE INCREASED 2 0.0000
988 EMOTIONAL DISTRESS 1 0.0000
989 DRY SKIN 1 0.0000
990 INJECTION SITE PAIN 2 0.0000
991 BACK PAIN 1 0.0000